TILT Biotherapeutics
PrivateLast Round
Series B
May 13, 2025
Total Funding Raised
$55.41M
Company Overview
TILT Biotherapeutics is a clinical-stage biotechnology company developing oncolytic immunotherapies to enable T-cell therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TILT Biotherapeutics Comps
Public and private peers based on sector, stage, and business model.
TILT Biotherapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 13, 2025 | ||||
| Series A Extension | Feb 7, 2023 | ||||
| Grant | Feb 7, 2023 | ||||
| Series A | Jun 14, 2022 | ||||
| Grant | Jun 16, 2020 | ||||
Seed | Dec 16, 2016 |
TILT Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series B, Series A Extension |
| Tesi | Series B, Series A |
| Business Finland | Grant |
| Lifeline Ventures | Series B, Seed, Series A |
| EIC Accelerator | Grant |
| Tekes | Seed |
| Stephen Industries Inc Oy | Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2025
$26M round completed.
- Feb 7, 2023
$11M Series A Extension round completed.
TILT Biotherapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about TILT Biotherapeutics's valuation, stock price, and market status.
